Deaths involving ‘Benzo Fury’, United Kingdom, 2011-2012. Carla Gimeno Clemente, Stefania Chiappini, Hugh Claridge, Christine Goodair, Barbara Loi International.

Slides:



Advertisements
Similar presentations
Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.
Advertisements

Delivering independent intelligence for health and wellbeing Background to NDTMS & TOP - a context for data collection Jill Smith Public Health Liaison.
Dr Paul Dargan & Dr David Wood Consultant Clinical Toxicologists Guy’s and St Thomas’ NHS Foundation Trust London, UK Monitoring Drug Emergencies How and.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
 Centre for Drug Misuse Research Glasgow Scotland From Harm Reduction to Abstinence: A Journey in Drug Treatment Pol From Harm Reduction to Abstinence:
Jennifer Hoolachan, PhD Candidate.  Youth literature focuses on recreational substance use  Homeless literature focuses on problematic substance use.
Drug-related deaths in England: latest data Martin White, Alcohol, Drugs and Tobacco Division, Public Health England.
Dr Richard Stevenson. Confusing terminology “Designer Drugs” “Bath Salts” “Legal Highs” “Psychoactive drugs, newly available in the UK, which are not.
European Early Warning System Charlotte Davies. European Early Warning System Adopted in May 2005, the Council Decision 2005/387/JHA on the information.
Prevalence of current substance misuse in psychiatric in-patients: Results of a survey in a University Teaching Hospital, Ireland. Brief report: Dr Ajay.
Tuberculosis in the UK 2013 report
1 Monitoring medical prescription in the Opole Voivodeship Branch of the NFZ Roman Kolek M.D.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
Response to Hidden Harm in Northern Ireland
INTRODUCTION FATALITIES ASSOCIATED WITH MEPHEDRONE IN COMBINATION WITH OTHER STIMULANT DRUGS IN YOUNG PEOPLE AGED YEARS Barbara Loi, Stefania Chiappini,
Cynhadledd Athrawon Teacher Conference Colwyn Bay Swansea, Nant Garw Camddefnyddio Sylweddau / Substance Misuse Camdrin Domestig / Domestic Abuse Diogelwch.
ABAB CONTEXT Despite widespread internet availability and use, many new drugs of abuse remain unfamiliar to health care providers. Methoxetamine (MXE),
Factors associated with fatal overdoses in Oslo Linn Gjersing, Thomas Clausen, Jørgen Bramness, Helge Waal, Stian Biong & Edle Ravndal.
Effects of Drug Abuse MDMA/Ecstasy
What do we tell the kids? New Psychoactive Drugs And Drug Education Prepared by: Ren Masetti BA Hons,PGCE, Cert Substance Misuse Suffolk DAAT Training.
SLIDE 1 of 34 IS THERE A CAUSAL RELATIONSHIP BETWEEN SUBSTANCE ABUSE AND PSYCHIATRIC ILLNESS? Dr Martin Frisher Department of Medicines Management Keele.
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
SOCIAL SERVICES CLUSTER SC PRESENTATION DEPARTMENT OF SOCIAL DEVELOPMENT 6/09/2005.
Needs Assessment: Young People’s Drug and Alcohol Services in Edinburgh City EADP Children, Young People and Families Network Event 7 th March 2012 Joanne.
Annual report 2010: the state of the drugs problem in Europe.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
Power B, McQuoid P, Caldwell NA, Clareburt A. Pharmacy Department, Wirral Hospital NHS Trust, Wirral. Poster Layout & Design By Wirral Medical Illustration.
Work-stream 2 – led by Dr Jacqueline Stair, with support from Dr Stewart Kirton, Professor Mire Zloh (all UH), with Professor Raffaele Giorgetti (Italy)
PORTFOLIO COMMITTEE AND NCOP PRESENTATION DEPARTMENT OF SOCIAL DEVELOPMENT 24/8/05.
Understanding Wales: Opportunities for Secondary Data Analysis Annual Population Survey/Labour Force Survey Melanie Jones School of Business.
26 th June 2008 Enforcement Task Force Conference 2008 Enforcement for all? Bill Blakemore Programme Manager, The SPARKS Programme.
Psychology 3.2 Alternatives to imprisonment. Psychology Learning outcomes Probation (Mair, G. and May, C. (1997) Offenders on Probation, Home Office Research.
GRAHAM WILKINSON National Offender Management Service TRANSFER OF SENTENCED PERSON COUNCIL FRAMEWORK DECISION 909: A UK PERSPECTIVE.
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
DRUGS - Current laws - Issue: Legalising Cannabis - Proposed changes to laws.
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
Portugal’s Gender Statistics Database: the Gender Profile Economic Commission for Europe Conference of European Statisticians Group of Experts on Gender.
An Overview of Drug Related Deaths in Scotland Andy Rome Director Figure 8 Consultancy Services Ltd.
NCI ANNUAL REPORT 2013 © National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. All rights reserved. Not to be reproduced.
Drug Misuse Monitoring Identifying Trends Predicting Future Demands Responding to Public Health Needs J McVeigh, MA Bellis & R Thomson.
Jack Stanley, Dr Daniel Mogford, Dr Rebecca Lawrence and Prof
SCOTTISH DRUGS FORUM SEMINAR 10 DECEMBER 2003 “Can Partnership Work Really Be Effective In Reducing Deaths” Presented By: Stephen Heath Vice-Chair Ayrshire.
The Need for Education on Novel Psychoactive Substances (“Legal Highs”) amongst Undergraduate Health Care Professionals Safia Akhtar
Website: eumadness.eu Novel Psychoactive Substances (NPS) - teaching of undergraduate healthcare professionals and educating the educators Society for.
Introduction Results and Conclusions Numerous demographic variables were found to be associated with treatment completion. Completers were more likely.
Opiate overdose. Opiate overdose (ONS, 2012) The most common acute cause of drug-related death is opiate overdose. Over half – 596 (57 per cent) - of.
NPS and Importance of Information Sharing Dr Richard Stevenson A&E Department, Glasgow Royal Infirmary Dr Hazel Torrance Forensic Medicine and Science.
Medical Drugs, Intoxication Substances, and Somatic Diseases Evgeniya Koshkina Deputy Director for Science Moscow Research and Practical Centre on Addictions.
A comprehensive evaluation of post- mortem findings and psychiatric case records of individuals who died by probable suicide. A van Laar, J Kielty, M Davoren,
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
Information Sources Focus: The Census October 2008 S.Mowers and the GSG team.
GOVERNMENT OFFICE FOR THE SOUTH WEST South West Public Health Observatory GOVERNMENT OFFICE FOR THE SOUTH WEST South West Public Health Observatory Drug.
Review of updates on the prevalence and epidemiology of Acetaminophen poisoning in the United States and the United Kingdom. Njoku Amara Chiemezie.L. Researcher.
Addressing the Federal Legalization of Cannabis Briefing to Standing Committee on Priorities and Planning June 7, 2017.
National Centre for Missing Persons & Unidentified Remains
Addressing the Federal Legalization of Cannabis Briefing to Standing Committee on Priorities and Planning June 7, 2017.
Conditional Release, Community Work & the new Probation Law
9. Introduction to signal detection
Professor Paul I Dargan
First year assessment of the French « cannabis outpatients clinics »
Results of an international drug testing service for cryptomarket users Mireia Ventura· ABD – Energy Control 15th May 2017.
The landscape of prescription drug misuse in the UK
Second European Conference on Addictive Behaviours and Dependencies
New Psychoactive Substances in Portugal
The Euro-Drug Emergencies Network (Euro-DEN) ED presentations with acute toxicity related to the misuse of prescription medicines Professor Paul.
Drugs the law & government responses
EMCDDA Work programme: outputs and communication
A. Al-Janabi1, Z. K. Jabbar-Lopez2, C.E.M. Griffiths1, Z.Z.N. Yiu1
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Risk Reduction on New Drugs,
Presentation transcript:

Deaths involving ‘Benzo Fury’, United Kingdom, Carla Gimeno Clemente, Stefania Chiappini, Hugh Claridge, Christine Goodair, Barbara Loi International Centre for Drug Policy, St George’s, University of London, Cranmer Terrace, London SW17 0RE 1. INTRODUCTION The novel psychoactive substance ‘Benzo Fury’ [5-(2-aminopropyl)benzofuran (5-APB) and 6-(2- aminopropyl)benzofuran (6-APB)] is an analogue of 3,4-methylenedioxyamphetamine (MDA). 2,10 It acts on dopamine transporters (DATs), which pump dopamine back into the nerve cells, and it also acts as a serotonin receptor agonist. 2,7,5,13 It is for these reasons that ‘Benzo Fury’ has similar effects as other known controlled drugs like amphetamines and ecstasy (with hallucinogenic and stimulant properties). 13,14 It is known to pose significant health risks, such as causing anxiety and cardiotoxicity and it has been noted that suppliers fail to include information relating to risks associated with its consumption. 2,6,7 At the time when the deaths reported here occurred, it was not a banned substance, and it was easily obtained from the internet and delivered by mail. 1,7,8 However, since 10 th June 2013, the Misuse of Drugs Act 1971 (Temporary Class Drug) Order 2013 subjects 5-APB and 6-APB and their related substances, to temporary control under the Misuse of Drugs Act The aim of this study was to discover the features of deaths involving ‘Benzo Fury’ in the UK between 2011 and METHODS  A literature search for “Benzo Fury”, “Benzofuran”, “6-APB”, “5-APB”, “legal highs” and “Novel Psychoactive Substances” using PubMed and Medline databases was conducted. As of April 2013, no confirmed deaths in the UK directly linked to Benzo Fury had been documented in the scientific literature.  Deaths involving ‘Benzo Fury’ (implicated in death and/or identified at post mortem toxicology) in the UK from were identified from the national programme on Substance Abuse Deaths ( np -SAD) database. The Programme has been collecting and analysing drug-related deaths in the UK since 1997, and maintains a database of more than 28,000 cases, with Coroners and relevant regional authorities voluntarily submitting information on drug-related deaths on a daily basis. 15  The general characteristics of these fatalities were analysed, using descriptive analysis with SPSS Statistics. 3. RESULTS  Ten cases were found with ‘Benzo Fury’ identified at post mortem.  ‘Benzo Fury’ was directly implicated in eight of these deaths.  In nine cases, ‘Benzo Fury’ was found in combination with other psychoactive substances at post mortem.  The majority were male (8/10).  The mean age at death was ± 1.98 years.  Where ethnicity was known, all were white.  The underlying cause of death was accidental poisoning in nine cases, with the remaining case attributed to poisoning of undetermined intent.  All deaths occurred between CONCLUSIONS  Our findings represent the largest known case series in the UK of deaths involving ‘Benzo Fury’.  This indicates a need for a Public Health education campaign on the risks of ‘Benzo Fury’ consumption, especially targeting young users and drugs education workers.  Further research into the toxicity of ‘Benzo Fury’ and the risks associated with its consumption is also needed. 5. ACKNOWLEDGMENTS This poster arises from the activity of the national programme on Substance Abuse Deaths ( np - SAD) team of the International Centre for Drug Policy, at St George’s University of London. Thanks in particular to John Corkery for technical advice and assistance in data preparation, and to Professor Fabrizio Schifano for his general supervision and for arranging the opportunity to work on the np -SAD programme at ICDP. For information on np- SAD and ICDP as a whole, either scan the QR barcode, or the team at REFERENCES 1.Bovens M, Schlapfer M. (2011) Designer drugs/ Research chemicals/ Legal highs – A survey of recent seizures and an attempt to a more effective handing from a Swiss perspective. Toxichem Krimtech. 788(Special Issue):167 2.Chan W L, Wood D M, Hudson S, Dargan P I. (2013) Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis. J Med. Toxicol. DOI /s y 3.Davies S, Wood D M, Smith G, Button J, Ramsey J, Archer R, Holt D W, Dargan P I. (2010) Purchasing ‘legal highs’ on the Internet - is there consistency in what you get? Q J Med. 103: European Monitoring Centre for Drugs and Drug Addiction (2005) EMCDDA-Europol 2005 Annual Report on the implementation of Council Decision 2005/387/JHA. Available at Accessed July 29th Iversen L, Gibbons S, Treble R, Setola V, Huang X, Roth B L. (2013) Neurochemical profiles of some novel psychoactive substances. European Journal of Pharmacology Ramsey J, Dargan P I, Smyllie M, Davies S, Button J, Holt D W, Wood D M. (2010) Buying ‘legal’ recreational drugs does not mean that you are not breaking the law. Q J Med. 103: Ratnapalan S. (2013) Legal substances and their abuse: Legal highs. Journal of Paramedic Practice. Vol 5 No 1 8.Schifano F, et al. (2006) Drugs on the web; the Psychonaut 2002 EU project. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 30, Schultz D M, Prescher J A, Kidd S, Marona-Lewicka D, Nichols D E, Monte A. (2008) ‘Hybrid’ benzofuran-benzopyran congeners as rigid analogs of hallucinogenic phenethylamines. Bioorganic and Medical Chemistry 16, Seetohul L N, Maskell P D, De Paoli G, Jounder D J. Deaths associated with new designer drug 5-IT. (2012) BMJ. 345:e Wood D M, Dargan P I. (2012) Understanding How Data Triangulation Identifies Acute Toxicity of Novel Psychoactive Drugs. J Medical Toxicol. 8: Wood D M, Davies S. (2012) Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol. 68: St Georges University of London. (2013) Legal high Benzo Fury may be dangerous due to stimulant and hallucinogenic effects. Available at news/legal-high-benzo-fury-may-be-dangerous-due-to-stimulant-and-hallucinogenic- effects. Accessed May Kelland K. (2013) ‘Legal high’ Benzo Fury may harbour addiction risk. Reuters Health Information. Available at idUSBRE93715V Accessed April Ghodse, H., Corkery, J., Claridge, H., Goodair, C., and Schifano, F. (2013) Drug-related deaths in the UK: Annual Report Drug-related deaths reported by Coroners in England, Wales, Northern Ireland, Guernsey, Jersey and the Isle of Man; Police forces in Scotland; & the Northern Ireland Statistics and Research Agency – Annual Report January-December London: International Centre for Drug Policy, St George’s University of London. Available at work-programmes/substance-abuse-deaths. Accessed May Home Office (2013) Home Office circular 008/2013: Misuse of Drugs Act 1971: Control of NBOMe and benzofuran substances under a Temporary Class Drug Order. Available at nbome-and-benzofuran. Accessed July 2013